These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma. Devillier P; Baccard N; Advenier C Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985 [TBL] [Abstract][Full Text] [Related]
3. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle. Jonsson EW Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121 [TBL] [Abstract][Full Text] [Related]
5. Treatment of asthma with antileukotrienes: first line or last resort therapy? Dahlén SE Eur J Pharmacol; 2006 Mar; 533(1-3):40-56. PubMed ID: 16510137 [TBL] [Abstract][Full Text] [Related]
6. Leukotrienes as mediators of airway obstruction and inflammation in asthma. Dahlén B; Dahlén SE Clin Exp Allergy; 1995 Nov; 25 Suppl 2():50-4. PubMed ID: 8590344 [No Abstract] [Full Text] [Related]
7. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle. Bäck M Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222 [TBL] [Abstract][Full Text] [Related]
8. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication. Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339 [TBL] [Abstract][Full Text] [Related]
9. [New developments in asthma therapy: how do individual leukotriene antagonists work?]. Wagener M Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455 [TBL] [Abstract][Full Text] [Related]
10. Anti-leukotriene agents: a new direction in asthma therapy. Nathan RA J Asthma; 1996; 33(6):353-66. PubMed ID: 8968291 [TBL] [Abstract][Full Text] [Related]
11. Leukotrienes in patients with clinically active multiple sclerosis. Neu IS; Metzger G; Zschocke J; Zelezny R; Mayatepek E Acta Neurol Scand; 2002 Jan; 105(1):63-6. PubMed ID: 11903112 [TBL] [Abstract][Full Text] [Related]
12. [Leukotriene antagonists in the treatment of asthma]. Mapp CE Ann Ital Med Int; 1998; 13(1):24-9. PubMed ID: 9642839 [TBL] [Abstract][Full Text] [Related]
13. Treatment of aspirin-intolerant asthma with antileukotrienes. Dahlén B Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S137-41. PubMed ID: 10673243 [No Abstract] [Full Text] [Related]
14. [Trend in chemical mediator research in asthma and its application for asthma treatment]. Fukuda T Nihon Kokyuki Gakkai Zasshi; 2003 Sep; 41(9):595-9. PubMed ID: 14531291 [No Abstract] [Full Text] [Related]
15. Direct evidence that LTC4 and LTB4 but not TXA2 are involved in asthma attacks in children. Zaitsu M; Hamasaki Y; Ishii K; Kita M; Hayasaki R; Muro E; Yamamoto S; Kobayashi I; Matsuo M; Ichimaru T; Miyazaki S J Asthma; 1998; 35(5):445-8. PubMed ID: 9734352 [TBL] [Abstract][Full Text] [Related]
17. An update on the role of leukotrienes in asthma. Hallstrand TS; Henderson WR Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):60-6. PubMed ID: 19915456 [TBL] [Abstract][Full Text] [Related]
18. Montelukast in childhood asthma: what is the evidence for its use? Amlani S; McIvor RA Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582 [TBL] [Abstract][Full Text] [Related]
19. Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. Rabinovitch N; Zhang L; Gelfand EW J Allergy Clin Immunol; 2006 Sep; 118(3):635-40. PubMed ID: 16950282 [TBL] [Abstract][Full Text] [Related]
20. Leukotrienes, airway hyperresponsiveness, and asthma. O'Byrne PM Ann N Y Acad Sci; 1988; 524():282-8. PubMed ID: 2837963 [No Abstract] [Full Text] [Related] [Next] [New Search]